Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Monoclonal [clone 13A37] (IgG2a) to Human C5b-9 Terminal Complement Complex / TCC
Human, Horse, Pig
IHC - Frozen, ICC, ELISA
Human C5b-9 Terminal Complement Complex / TCC
Human, Horse, Pig (tested or 100% immunogen sequence identity)
IgG2a Monoclonal [13A37]
Protein G purified
IHC - Frozen
Specificity and Use
A C9 neoantigen of the human TCC.
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. Sensitive to light.
For research use only.
About C5b-9 Terminal Complement Complex / TCC
The membrane attack complex (MAC) or terminal complement complex (TCC) is a structure typically formed on the surface of pathogenic bacterial cells as a result of the activation of the host's alternative pathway, classical pathway, or lectin pathway of the complement system, and it is one of the effector proteins of the immune system. The membrane-attack complex (MAC) forms transmembrane channels. These channels disrupt the phospholipid bilayer of target cells, leading to cell lysis and death.